These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23299288)

  • 41. Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis.
    Smith-Spangler CM; Juusola JL; Enns EA; Owens DK; Garber AM
    Ann Intern Med; 2010 Apr; 152(8):481-7, W170-3. PubMed ID: 20194225
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk.
    Murray CJ; Lauer JA; Hutubessy RC; Niessen L; Tomijima N; Rodgers A; Lawes CM; Evans DB
    Lancet; 2003 Mar; 361(9359):717-25. PubMed ID: 12620735
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Within trial cost-utility analysis of disease management program for patients hospitalized with atrial fibrillation: results from the SAFETY trial.
    Byrnes J; Ball J; Gao L; Kai Chan Y; Kularatna S; Stewart S; Scuffham PA
    J Med Econ; 2019 Sep; 22(9):945-952. PubMed ID: 31190590
    [No Abstract]   [Full Text] [Related]  

  • 44. Cost-effectiveness analysis of population salt reduction interventions to prevent cardiovascular disease in Cameroon: mathematical modelling study.
    Aminde LN; Cobiac L; Veerman JL
    BMJ Open; 2020 Nov; 10(11):e041346. PubMed ID: 33234652
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The economic impact of implementing a multiple inflammatory biomarker-based approach to identify, treat, and reduce cardiovascular risk.
    Penn MS; Yenikomshian MA; Cummings AK; Klemes A; Damron JM; Purvis S; Beidelschies M; Birnbaum HG
    J Med Econ; 2015; 18(7):483-91. PubMed ID: 25763924
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prescribing Smartphone Apps for Physical Activity Promotion in Primary Care: Modeling Study of Health Gain and Cost Savings.
    Grout L; Telfer K; Wilson N; Cleghorn C; Mizdrak A
    J Med Internet Res; 2021 Dec; 23(12):e31702. PubMed ID: 34931993
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Health Impact and Cost-Effectiveness of Volume, Tiered, and Absolute Sugar Content Sugar-Sweetened Beverage Tax Policies in the United States: A Microsimulation Study.
    Lee Y; Mozaffarian D; Sy S; Liu J; Wilde PE; Marklund M; Abrahams-Gessel S; Gaziano TA; Micha R
    Circulation; 2020 Aug; 142(6):523-534. PubMed ID: 32564614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The health, cost and equity impacts of restrictions on the advertisement of high fat, salt and sugar products across the transport for London network: a health economic modelling study.
    Thomas C; Breeze P; Cummins S; Cornelsen L; Yau A; Brennan A
    Int J Behav Nutr Phys Act; 2022 Jul; 19(1):93. PubMed ID: 35897072
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa.
    Gaziano TA
    Heart; 2008 Feb; 94(2):140-4. PubMed ID: 18195120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reducing population salt intake worldwide: from evidence to implementation.
    He FJ; MacGregor GA
    Prog Cardiovasc Dis; 2010; 52(5):363-82. PubMed ID: 20226955
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reducing salt intake for prevention of cardiovascular diseases in high-risk patients by advanced health education intervention (RESIP-CVD study), Northern Thailand: study protocol for a cluster randomized trial.
    Aung MN; Yuasa M; Moolphate S; Nedsuwan S; Yokokawa H; Kitajima T; Minematsu K; Tanimura S; Fukuda H; Hiratsuka Y; Ono K; Kawai S; Marui E
    Trials; 2012 Sep; 13():158. PubMed ID: 22947342
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reducing salt intake to prevent hypertension and cardiovascular disease.
    He FJ; Campbell NR; MacGregor GA
    Rev Panam Salud Publica; 2012 Oct; 32(4):293-300. PubMed ID: 23299291
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost effectiveness of a government supported policy strategy to decrease sodium intake: global analysis across 183 nations.
    Webb M; Fahimi S; Singh GM; Khatibzadeh S; Micha R; Powles J; Mozaffarian D
    BMJ; 2017 Jan; 356():i6699. PubMed ID: 28073749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiovascular disease and impoverishment averted due to a salt reduction policy in South Africa: an extended cost-effectiveness analysis.
    Watkins DA; Olson ZD; Verguet S; Nugent RA; Jamison DT
    Health Policy Plan; 2016 Feb; 31(1):75-82. PubMed ID: 25841771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The cost-effectiveness of interventions designed to reduce sodium intake.
    Wang G; Labarthe D
    J Hypertens; 2011 Sep; 29(9):1693-9. PubMed ID: 21785366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness analysis of salt reduction policies to reduce coronary heart disease in Syria, 2010-2020.
    Wilcox ML; Mason H; Fouad FM; Rastam S; al Ali R; Page TF; Capewell S; O'Flaherty M; Maziak W
    Int J Public Health; 2015 Jan; 60 Suppl 1():S23-30. PubMed ID: 24972676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The economic benefits of reducing physical inactivity: an Australian example.
    Cadilhac DA; Cumming TB; Sheppard L; Pearce DC; Carter R; Magnus A
    Int J Behav Nutr Phys Act; 2011 Sep; 8():99. PubMed ID: 21943093
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effectiveness of different screening strategies for primary prevention of cardiovascular diseases in a rural northern Chinese population].
    Si YQ; Tang X; Zhang DD; He L; Cao Y; Wang JW; Li N; Liu JJ; Gao P; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):443-449. PubMed ID: 29930411
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.